nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Against all odds
|
Nuechterlein, Brandon |
|
|
10 |
9 |
p. e709 |
artikel |
2 |
All systems are not GO: ongoing challenges in interpreting gemtuzumab ozogamicin clinical trial results
|
Kelkar, Amar H |
|
|
10 |
9 |
p. e706-e707 |
artikel |
3 |
All systems are not GO: ongoing challenges in interpreting gemtuzumab ozogamicin clinical trial results – Authors' reply
|
Döhner, Hartmut |
|
|
10 |
9 |
p. e707 |
artikel |
4 |
Association between maternal haemoglobin concentrations and maternal and neonatal outcomes: the prospective, observational, multinational, INTERBIO-21st fetal study
|
Ohuma, Eric O |
|
|
10 |
9 |
p. e756-e766 |
artikel |
5 |
Correction to Lancet Haematol 2023; 10: e512–29
|
|
|
|
10 |
9 |
p. e708 |
artikel |
6 |
Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial
|
Lasocki, Sigismond |
|
|
10 |
9 |
p. e747-e755 |
artikel |
7 |
FIT for surgery: fractures, iron, and tranexamic acid
|
Ikeda, Kazuhiko |
|
|
10 |
9 |
p. e699-e700 |
artikel |
8 |
Haematological malignancies in pregnancy: time for accurate incidence data
|
Birsen, Rudy |
|
|
10 |
9 |
p. e705 |
artikel |
9 |
Haematological malignancies in pregnancy: time for accurate incidence data – Authors' reply
|
Mills, Georgia S |
|
|
10 |
9 |
p. e705-e706 |
artikel |
10 |
Maintaining MOMENTUM in myelofibrosis
|
Kremyanskaya, Marina |
|
|
10 |
9 |
p. e697-e699 |
artikel |
11 |
Measuring the global burden of anaemia
|
Pasricha, Sant-Rayn |
|
|
10 |
9 |
p. e696-e697 |
artikel |
12 |
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
|
Gerds, Aaron T |
|
|
10 |
9 |
p. e735-e746 |
artikel |
13 |
Optimal haemoglobin concentration in pregnancy
|
Olaniyan, Halimat |
|
|
10 |
9 |
p. e700-e702 |
artikel |
14 |
Patients receiving allogeneic haematopoietic stem-cell transplantation and clinical outcomes after early access to palliative care
|
Späth, Christian |
|
|
10 |
9 |
p. e777-e784 |
artikel |
15 |
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
|
|
|
|
10 |
9 |
p. e713-e734 |
artikel |
16 |
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts
|
Shallis, Rory M |
|
|
10 |
9 |
p. e767-e776 |
artikel |
17 |
Tackling the enormous global burden of anaemia
|
The Lancet Haematology, |
|
|
10 |
9 |
p. e695 |
artikel |
18 |
The challenge of defining the global burden of iron deficiency anaemia
|
Young, Melissa F |
|
|
10 |
9 |
p. e702-e704 |
artikel |
19 |
Understanding the barriers to AML care in India
|
Senapati, Jayastu |
|
|
10 |
9 |
p. e710-e711 |
artikel |
20 |
Virginia Abello Polo—a once-in-a-lifetime opportunity
|
Kirby, Tony |
|
|
10 |
9 |
p. e712 |
artikel |